Depixus raised €31M in a Series A round in Dec 2021. The company is based in Paris, France. Investors in the round: Arix Bioscience, Casdin Capital, Lansdowne Partners and 1 other. Data as of 6 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
